UBS Group reaffirmed their buy rating on shares of Reckitt Benckiser Group (LON:RKT – Free Report) in a research note published on Friday morning, MarketBeat.com reports. They currently have a GBX 7,700 price objective on the stock.
Several other analysts have also commented on the stock. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 5,200 price objective on shares of Reckitt Benckiser Group in a research report on Thursday, October 2nd. Berenberg Bank lowered their price target on shares of Reckitt Benckiser Group from GBX 5,920 to GBX 5,555 and set a “hold” rating on the stock in a report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a GBX 5,300 price target on shares of Reckitt Benckiser Group in a report on Monday, July 21st. Finally, Royal Bank Of Canada boosted their target price on Reckitt Benckiser Group from GBX 5,700 to GBX 6,000 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Reckitt Benckiser Group presently has a consensus rating of “Hold” and an average target price of GBX 5,951.
View Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 1.8%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The company reported GBX 141.20 earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. Analysts expect that Reckitt Benckiser Group will post 331.2110727 EPS for the current year.
Insider Buying and Selling
In related news, insider Jeremy Darroch purchased 1,652 shares of the firm’s stock in a transaction dated Tuesday, July 29th. The shares were purchased at an average cost of GBX 5,649 per share, for a total transaction of £93,321.48. Also, insider Tamara Ingram purchased 293 shares of the firm’s stock in a transaction dated Wednesday, July 30th. The shares were bought at an average price of GBX 5,626 per share, for a total transaction of £16,484.18. In the last 90 days, insiders have purchased 2,212 shares of company stock valued at $12,488,849. 0.42% of the stock is owned by company insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- What is the Euro STOXX 50 Index?
- This AI Chip Giant Could Be the Market’s Next Big Winner
- Industrial Products Stocks Investing
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- How to Use Stock Screeners to Find Stocks
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.